Document Detail


Nitric oxide modulation of low-frequency oscillations in cortical vessels in FHM--a NIRS study.
MedLine Citation:
PMID:  22352839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The pathophysiological alterations in patients with familial hemiplegic migraine (FHM) are not yet fully known. The headache characteristics in patients with FHM mutations have been examined in a series of glyceryl trinitrate (GTN) provocation studies in FHM patients, but the cortical vascular response to GTN in FHM patients has never been investigated before.
OBJECTIVE: To investigate changes in spontaneous low-frequency oscillations (LFO) of cortical vessels in response to the nitric oxide donor GTN by near-infrared spectroscopy in FHM patients.
METHODS: Twenty-three FHM patients without known mutations and 9 healthy controls received a continuous intravenous infusion of GTN 0.5 µg/kg/minute over 20 minutes. Using near-infrared spectroscopy, we recorded oxygenated hemoglobin (oxyHb) LFO amplitude bilateral at the frontal cortex at baseline and 15 minutes and 40 minutes after start of the GTN infusion.
RESULTS: GTN changed oxyHb LFO amplitude in FHM patients (P = .002), but not in healthy controls (P = .121). Only in FHM patients with coexisting common migraine types did GTN infusion induced changes in LFO amplitudes (P < .001), where post-hoc analysis revealed an increase in LFO amplitude 15 minutes (P = .003) and 40 (P = .013) minutes after start of infusion compared with baseline. Interestingly, GTN infusion induced no changes in LFO amplitude in patients with a pure FHM phenotype (P = .695).
CONCLUSION: FHM patients with a mixed phenotype (coexisting common type of migraine) showed an increase in oxyHb LFO amplitude during GTN infusion, whereas FHM patients with pure phenotype showed no changes. These data suggest possible differences in frontal cortical nitric oxide vascular sensitivity between FHM patients with a mixed phenotype and patients with pure FHM.
Authors:
Henrik W Schytz; Jakob M Hansen; Dorte Phillip; Juliette Selb; David A Boas; Messoud Ashina
Related Documents :
1679339 - Activities of dipeptidyl peptidase ii, dipeptidyl peptidase iv, prolyl endopeptidase, a...
11681539 - Serum levels of parathyroid hormone and markers of bone metabolism in patients with rhe...
12048289 - Dose titration using the disease activity score (das28) in rheumatoid arthritis patient...
2181669 - The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis.
10555039 - Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of pa...
19181509 - Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases.
23543149 - Usefulness of a guiding sheath for fluoroscopic stent placement in patients with malign...
11418799 - Synchronous gastric adenocarcinomas in a patient with meckel's diverticulum.
19786739 - Hemoglobin level variability: anemia management among variability groups.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-02-21
Journal Detail:
Title:  Headache     Volume:  52     ISSN:  1526-4610     ISO Abbreviation:  Headache     Publication Date:    2012 Jul-Aug
Date Detail:
Created Date:  2012-07-04     Completed Date:  2012-11-27     Revised Date:  2013-08-14    
Medline Journal Info:
Nlm Unique ID:  2985091R     Medline TA:  Headache     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1146-54     Citation Subset:  IM    
Copyright Information:
© 2012 American Headache Society.
Affiliation:
Danish Headache Center and Department of Neurology, Glostrup Hospital, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Vessels / drug effects,  metabolism*
Case-Control Studies
Cerebral Cortex / blood supply*
Female
Frontal Lobe / blood supply
Hemoglobins / metabolism
Humans
Male
Middle Aged
Migraine with Aura / metabolism*
Nitric Oxide / metabolism*
Nitric Oxide Donors / pharmacology
Nitroglycerin / pharmacology
Phenotype
Spectroscopy, Near-Infrared*
Time Factors
Grant Support
ID/Acronym/Agency:
R01 CA142575/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Hemoglobins; 0/Nitric Oxide Donors; 10102-43-9/Nitric Oxide; 55-63-0/Nitroglycerin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metabolic Adaptation To A Disruption In Oxygen Supply During Myocardial Ischemia And Reperfusion Is ...
Next Document:  Impact of time to start treatment following infection with application to initiating HAART in HIV-po...